Cited by 211Telomeres, Telomerase, and SenescenceCancer-related Molecular PathwaysGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index, and 1 are not checked yet.

Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms

Horikawa, I., Barrett, J. C.·2003·Carcinogenesis

Abstract

Malignant transformation from mortal, normal cells to immortal, cancer cells is generally associated with activation of telomerase and subsequent telomere maintenance. A major mechanism to regulate telomerase activity in human cells is transcriptional control of the telomerase catalytic subunit gene, human telomerase reverse transcriptase (hTERT). Several transcription factors, including oncogene products (e.g. c-Myc) and tumor suppressor gene products (e.g. WT1 and p53), are able to control hTERT transcription when over-expressed, although it remains to be determined whether a cancer-associated alteration of these factors is primarily responsible for the hTERT activation during carcinogenic processes. Microcell-mediated chromosome transfer experiments have provided evidence for endogenous factors that function to repress the telomerase activity in normal cells and are inactivated in cancer cells. At least one of those endogenous telomerase repressors, which is encoded by a putative tumor suppressor gene on chromosome 3p, acts through transcriptional repression of the hTERT gene. The hTERT gene is also a target site for viruses frequently associated with human cancers, such as human papillomavirus (HPV) and hepatitis B virus (HBV). HPV E6 protein contributes to keratinocyte immortalization and carcinogenesis through trans-activation of the hTERT gene transcription. In at least some hepatocellular carcinomas, the hTERT gene is a non-random integration site of HBV genome, which activates in cis the hTERT transcription. Thus, a variety of cellular and viral oncogenic mechanisms converge on transcriptional control of the hTERT gene. Regulation of chromatin structure through the modification of nucleosomal histones may mediate the action of these cellular and viral mechanisms. Further elucidation of the hTERT transcriptional regulation, including identification and characterization of the endogenous repressor proteins, should lead to better understanding of the complex regulation of human telomerase in normal and cancer cells and may open up new strategies for anticancer therapy.

Overview

Integrity signals

Registry

Crossref · 10.1093/carcin/bgg085

Cites

124 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 125 references

Research works printed but not linked: 19

  1. 2000, J ANTIAGING MED, 3, 373
  2. Horikawa, 1999, Cancer Research, 59, 826
  3. Takakura, 1999, Cancer Research, 59, 551
  4. Gunes, 2000, Cancer Research, 60, 2116
  5. 1992, N BIOL, 4, 97
  6. Yang, 2001, Cell Growth & Differentiation, 12, 119
  7. Ducrest, 2001, Cancer Research, 61, 7594
  8. 1984, SURV SYNTH PATH RES, 3, 342
  9. Zhang, 2000, Cancer Research, 60, 6230
  10. Devereux, 1999, Cancer Research, 59, 6087
  11. Dessain, 2000, Cancer Research, 60, 537
  12. Kitagawa, 2000, Clinical Cancer Research, 6, 2868
  13. McGregor, 2002, Cancer Research, 62, 4757
  14. Wang, 2000, Cancer Research, 60, 5376
  15. Alfonso-De Matte, 2002, Cancer Research, 62, 4575
  16. Dimri, 2002, Cancer Research, 62, 4736
  17. Kyo, 1999, Cancer Research, 59, 5917
  18. Guo, 2000, Cancer Research, 60, 5922
  19. Braunstein, 2001, Cancer Research, 61, 5529

Cited by

Items 201–211 of 211

Metadata

Authors
Horikawa, I., & Barrett, J. C.
Affiliations
National Institutes of Health (US)
Corresponding author
Horikawa, I.
Venue
Carcinogenesis
Published
2003-05-22
Volume
24
Issue
7
Pages
1167-1176
ISSN
  • 0143-3334 (ISSN-L)
  • 1460-2180
OpenAlex
W2170172182
Cited by
211
References
125
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2022: 2 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 4 · 2014: 13 · 2013: 11 · 2012: 8
FWCI
1.02
Type
journal article
Language
en
Open access
closed
Locations
  • Carcinogenesis (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Georgetown University
  • Korea Advanced Institute of Science and Technology
  • National Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
hTERT, telomerase, transcriptional regulation, telomere maintenance, c-Myc, WT1, p53, E6 oncoprotein, hepatitis B virus, viral oncogenesis, chromatin structure, histone modifications, cell immortalization, hepatocellular carcinoma, cancer therapy
MeSH terms
Cell Transformation, Viral, DNA-Binding Proteins, Humans, Transcription, Genetic, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Telomere, Telomerase, DNA Methylation, Papillomaviridae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review